Navigation Links
Sequella and University of Maryland Restate Exclusive License for Jointly Owned Event Marker System Technology
Date:8/30/2010

ROCKVILLE, Md., Aug. 30 /PRNewswire/ -- Sequella, Inc., a clinical-stage company focused on commercialization of novel drugs for life-threatening infectious diseases, announced today the restatement of its exclusive international license agreement with the University of Maryland, Baltimore (UMB), concerning certain technology related to monitoring drug therapy compliance.  The issued technology patent (U.S. 6,663,846), jointly owned by Sequella and UMB, addresses transdermal detection of a labeled pill to monitor drug compliance. Non-compliance with drug regimens contributes $290 billion in annual costs to the United States healthcare system.

"With recent technological advances, the market for drug compliance monitoring represents a tremendous opportunity for many pharmaceutical industry sectors, including those concerned with drug compliance, manufacturing, anti-counterfeiting, and clinical trial conduct," said Sequella CEO, Carol Nacy.  "We are pleased to strengthen our relationship with UMB to enhance development and marketing of our assets."

Sequella's Event Marker System (EMS) for transdermal drug compliance monitoring uses a wristwatch device to detect labeled pills.  

"Our exclusive license agreement with UMB is a classic win-win for both parties," said Alan Klein, Executive Vice President of Corporate Development for Sequella. "We look forward to playing a key role in the rapidly expanding marketplace for drug compliance monitoring."

"We are delighted to continue this relationship with Sequella to bring this exciting technology to market," said James L. Hughes, Vice President, Research and Development, University of Maryland.

About the Technology

The '846 patent includes "a method for monitoring drug therapy compliance, by human or animal patient, comprising contacting the patient with a transdermal detection device capable of receiving a signal from a labeled pill administered to the patient
'/>"/>

SOURCE Sequella, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Sequella Receives American Recovery and Reinvestment Funding Through the NIH
2. Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program
3. Sequella Presents Data on Synergy Between Investigational New TB Drugs SQ109 and TMC207
4. Siteman Cancer Center at Barnes-Jewish and Washington University to Receive First ViewRay Radiation Therapy System
5. Bayer HealthCare Pharmaceuticals Supports New Jersey Governors School in the Sciences at Drew University
6. SRI International and Stanford University School of Medicines MISTRAL Collaborative and the Institute for Pediatric Innovation Awarded FDA Grant to Accelerate Commercialization of Pediatric Medical Devices
7. Health Robotics CytoCare Continues European Expansion With Grifols and Vall dHebron University Hospital
8. University of Luebeck Joins GeneGos Metaminer Cardiac Project
9. University HealthSystem Consortium Awards Single-Source Agreement to Ascent for Medical Device Reprocessing Services
10. Biospherics Acquires Global Patent Rights from University of Kentucky Research Foundation to Develop Tagatose as a Trigylcerides Therapy
11. Ethicon Endo-Surgery Extends Research Partnership with $13.5 Million Grant to University of Cincinnati
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... and BOSTON , May 24, 2013 ... company, is pleased to announce that it has engaged Mr ... Company,s business development capabilities in Japan and ... years of experience in business development, licensing and alliance management in ... Pharma ( Japan ), Nippon Roche and Tanabe Seiyaku ...
(Date:5/23/2013)... OAKS, Calif. , May 23, 2013 Amgen ... Bank 38 th Annual  Healthcare Conference on Thursday, May ... Boston , beginning at 9:20 a.m. Eastern Daylight Time. ... Relations at Amgen, will present at the conference. Live audio ... on Amgen,s website, www.amgen.com , under Investors. A replay ...
(Date:5/23/2013)... 2013  A recently published clinical study conducted at ... , demonstrates that 3D mammography (breast tomosynthesis) significantly ... The study, "Implementation of Breast Tomosynthesis in ... by Stephen L. Rose , MD, ... American Journal of Roentgenology (AJR). The AJR is ...
Breaking Medicine Technology:Heptares Augments Business Development Capabilities in Japan and Other Asian Territories 2First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 2First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 3
... /PRNewswire-iReach/ -- CoLucid Pharmaceuticals, Inc., a ... has raised $7.5 million of a planned $9.5 ... to support further late stage development of lasmiditan.  ... Associates, Care Capital, Pearl Street Venture Funds and ...
... DIEGO, Aug. 30, 2011 aTyr Pharma , ... to aTyr,s leadership team of Dr. Jeffrey Greve, as ... president, intellectual property. Drs. Greve and Cubitt will support ... on Physiocrine biology. Physiocrines are naturally occurring human proteins ...
Cached Medicine Technology:CoLucid Pharmaceuticals Raises $7.5 Million of Planned $9.5 Million 2aTyr Pharma Expands Leadership Team to Advance New Breakthrough Medicines Based on Physiocrine Biology 2aTyr Pharma Expands Leadership Team to Advance New Breakthrough Medicines Based on Physiocrine Biology 3
(Date:5/24/2013)... 24 (HealthDay News) -- People with high levels of ... die of liver disease than those with lower levels, ... cadmium in urine is evidence of long-term exposure to ... and tobacco smoke, the Johns Hopkins researchers explained. ... cadmium directly causes liver disease but instead suggest an ...
(Date:5/24/2013)... Seattle, WA (PRWEB) May 24, 2013 ... consider when picking out a home security monitoring ... comparisons help make 6Webs.com the useful resource consumers prefer ... recently completed performing their evaluations of the leading wireless ... home security companies are rated on a number of ...
(Date:5/24/2013)... 2013 According to a May 15, 2013 ... Leads to Spikes in Plastic Surgery Requests,” a ... prevalence of facial plastic surgery and cosmetic improvements ... become keenly aware of the need to look good online ... Google and even Skype's video chat feature (Go to goo.gl/WO0PR). ...
(Date:5/24/2013)... LONG BEACH, CA (PRWEB) May 24, 2013 ... California's health care education community, proudly participated in festivities ... on April 19-21. The event provided the perfect backdrop ... and facilities at 236 E. 3rd Street, housed in ... the Arts Building. , ACC was an active exhibitor ...
(Date:5/24/2013)... May 24 (HealthDay News) -- The number of ... after spending time in an emergency room has ... research. The study, conducted by researchers at ... and Health Services in Washington, D.C., found that ... on average before being admitted to the ICU. ...
Breaking Medicine News(10 mins):Health News:High Cadmium Levels May Raise Risk for Dying From Liver Disease: Study 2Health News:2013 Best Wireless Security System Providers Reported by 6Webs.com 2Health News:Facebook and Google – Is Social Media Driving Demand for Plastic Surgery? 2Health News:American Career College Revs Up Community Support During Toyota Grand Prix of Long Beach 2Health News:Sharp Rise in ICU Admissions From U.S. Emergency Rooms 2
... IM), As part of an ongoing commitment to ... Portland, Ore. today announced its,investment in the world,s most ... be the first medical center on the West,Coast - ... to house IMRISneuro; a fully,integrated operating room that combines ...
... corporate infrastructure and provide ... tactical and strategic market advantages, HARRISBURG, Pa., ... a rapidly growing, national medical management,firm has promoted two ... Meghan Harris, MS, is KePRO,s new Vice,President, Informatics and ...
... (Nasdaq: ONXX ) today announced that it ... Conference on Thursday,May 1, at 8:00 a.m. Eastern ... of the presentation on our website at:, ... listeners log on 15 minutes early in order ...
... Protect Against Healthcare and Employment,Discrimination, BAYSIDE, ... Association, Inc. (TSA), hailed today,s vote in ... Genetic,Information Nondiscrimination Act (GINA), to ban genetic ... of Representatives passed GINA,in April 2007., ...
... Bliss Products Bring Blissful Comfort to Mothers-to-Be, SAN ... at the,end of the first trimester -- this is ... can really start enjoying their pregnancy.,However, those, who wish ... turn to magic. Mommy,s Bliss Morning Sickness Magic(TM) is,the ...
... and Quality of Care Rank as Top Factors in Choosing the Right ... ... the age of 50 expect an immediate family member to move into a ... of,65 expect the same for themselves, according to a new national survey of,American ...
Cached Medicine News:Health News:Providence St. Vincent bringing IMRISneuro, the world's most advanced surgical MRI to Portland, Oregon 2Health News:Providence St. Vincent bringing IMRISneuro, the world's most advanced surgical MRI to Portland, Oregon 3Health News:KePRO Appoints Two New IT Vice Presidents 2Health News:KePRO Appoints Two New IT Vice Presidents 3Health News:Tourette Syndrome Association Applauds the Passage of Genetic Information Nondiscrimination Act 2Health News:Morning Sickness Magic(TM) - An Effective Natural Approach to Morning Sickness 2Health News:New National Survey: 84% of Americans Over 50 Expect a Family Member to Move into an Assisted Living Community Within the Next 10 Years 2
Shandon Paraffin Block Cartons...
The Modular Storage Drawers provide permanent storage and identification of up to 165 embedding rings or 250 cassettes per drawer....
Cardboard Block Filing Cabinet is an economical solution for block storage needs....
Shandon Carousel Cassette MicroWriter™ is a carousel-type cassette marking system....
Medicine Products: